1. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53
   YUN-JEONG CHOE et al, 2014 CrossRef
2. Nutlin-3 induces BCL2A1 expression by activating ELK1 through the mitochondrial p53-ROS-ERK1/2 pathway
   SUN-YOUNG LEE et al, 2014 CrossRef
3. Wilms’ tumor gene 1 enhances nutlin-3-induced apoptosis
   SUN-YOUNG LEE et al, 2014 CrossRef
4. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
   Fangyi Chen et al, 2018, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
5. Dynamics of p53 and Wnt cross talk
   Md. Zubbair Malik et al, 2015, Computational Biology and Chemistry CrossRef
6. p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells
   Mohamad Harajly et al, 2016, Mol. Cell. Biol. CrossRef
7. ATM regulates cell fate choice upon p53 activation by modulating mitochondrial turnover and ROS levels
   Kelly D Sullivan et al, 2015, Cell Cycle CrossRef
8. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis.
   Yu Sun et al, 2015, J Recept Signal Transduct Res CrossRef
9. Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin
   Audrey Laroche et al, 2015, PLoS ONE CrossRef
10. The relationship between p53/p21/Rb and MAPK signaling pathways in human endometrium-derived stem cells under oxidative stress
    P. I. Deryabin et al, 2016, Cell Tiss. Biol. CrossRef
11. Rearrangement of mitochondrial pyruvate dehydrogenase subunit dihydrolipoamide dehydrogenase protein-protein interactions by the MDM2 ligand nutlin-3.
    Luke Way et al, 2016, Proteomics CrossRef
12. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53
    Chen Qiao et al, 2016, Oncotarget CrossRef
13. Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma
    Xin Huang et al, 2020, Clin. Transl. Med. CrossRef
14. MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
    Shomereeta Roy et al, 2020, Cancers CrossRef
15. Zearalenone Induces Endothelial Cell Apoptosis through Activation of a Cytosolic Ca2+/ERK1/2/p53/Caspase 3 Signaling Pathway
    Hyeon-Ju Lee et al, 2021, Toxins CrossRef
16. Mycobacterium tuberculosis RKIP (Rv2140c) dephosphorylates ERK/NF-κB upstream signaling molecules to subvert macrophage innate immune response
    M.A. Abo-Kadoum et al, 2021, Infection, Genetics and Evolution CrossRef
17. Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?
    Lucia Haronikova et al, 2021, Cell Mol Biol Lett CrossRef
18. Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
    Tycho de Bakker et al, 2022, Front. Oncol. CrossRef
19. MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma
    Arianna Romani et al, 2022, Front. Oncol. CrossRef
20. Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage
    Elisabetta Esposito et al, 2024, Life CrossRef
21. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
    Reiko Sugiura et al, 2021, Cells CrossRef
22. Banhasasim‐Tang Ameliorates Spatial Memory by Suppressing Oxidative Stress through Regulation of ERK/p38 Signaling in Hippocampus of Mice
    Malk Eun Pak et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
23. Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
    Hyun Hee Kim et al, 2024, Cancers CrossRef